CN1840200A - Folacin-starch nanometer granule, its preparation method and application - Google Patents
Folacin-starch nanometer granule, its preparation method and application Download PDFInfo
- Publication number
- CN1840200A CN1840200A CNA2006100311063A CN200610031106A CN1840200A CN 1840200 A CN1840200 A CN 1840200A CN A2006100311063 A CNA2006100311063 A CN A2006100311063A CN 200610031106 A CN200610031106 A CN 200610031106A CN 1840200 A CN1840200 A CN 1840200A
- Authority
- CN
- China
- Prior art keywords
- folacin
- starch
- nanometer granule
- starch nanometer
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
This invention discloses a kind of folacin-starch nanogranule and its preparation method and its application as tumour target-effect drug carrier. This invention is aimed to provide the nanogranule drug carrier that is biodegradable, technics simple, cost low, and can greatly enhance antineoplastic drug effect, this invention also provides the nanogranule's preparation and application. The drug carrier is produced by combining anion crosslinked starch nanogranules and polietilenglicol derivatives; it can wrap electropositive or neutral antineoplastic drugs, slow drug release and reduce drug toxicity; the carrier enters into tumor cells by means of folacin- folacin acceptor guiding; thereby the drug availability is heightened and drug side effect is reduced.
Description
Technical field
The present invention relates to of the research and development of biological nano material, more particularly, the invention relates to folacin-starch nanometer granule as the target medicine carrier of antitumor drug and preparation method thereof at field of medicaments.
Background technology
The low toxicity of medicine and efficient very important, and as the carrier of medicine to the clinical treatment of disease, how effectively with drug delivery to object, and reach the effect of treatment, also be a very problem of crux.Therefore, the targeted delivery research of medicine more and more is subjected to medicine worker's attention in recent years.In addition, relevant nano-particle is big as the binding capacity that pharmaceutical carrier had, good stability, the characteristics that are easy to control also are subjected to medicine worker's further research.How effectively to utilize nano-particle better, make its portability active drug enter into the human cell that focuses on one of disease malignant tumor, realizing the bioavailability of medicament slow release, cancer target, raising medicine, the effect of reduction poisonous side effect of medicine, is the important subject of medicine worker in long one period from now on.
Summary of the invention
Purpose of the present invention aims to provide a kind of Stability Analysis of Structures, has no side effect, and is with low cost, and tumor cell is had very strong targeting, also has the folacin-starch nanometer granule of good biocompatibility, degradability and non-immunogenicity.
Another purpose of the present invention aims to provide the preparation method of above-mentioned folacin-starch nanometer granule.
A present invention also purpose is with the application of above-mentioned folacin-starch nanometer granule as the tumor-targeting pharmaceutical carrier.
The objective of the invention is to realize by following manner:
Folacin-starch nanometer granule of the present invention is to be modified with active substance folic acid-amination Polyethylene Glycol on the anionic starch nano-particle.
The present invention is based on another patent application of the inventor: " 03124513.7; poly-D-lysine starch nanometer granule and preparation method and as the application of genophore " on the basis of the starch nanometer granule that prepared, folic acid in the starch nanometer granule finishing-amination Polyethylene Glycol (FA-PEG) active substance.The folacin-starch nanometer granule of being invented is by amino on active substance folic acid-amination Polyethylene Glycol and the anion be combined on the anionic starch nano-particle.
The folacin-starch nanometer granule of being invented, by weight, the proportion that folic acid accounts for starch nanometer granule is 0.5-2.0 microgram/milligram.
Preparation method realizes by following manner in the another object of the present invention:
(1) preparation of starch nanometer granule: starch is made into aqueous solution, adds thermal decomposition in the boiling water, up to the solution clarification, room temperature is placed cooling; The oil phase that preparation is made up of toluene and chloroform adds surfactant SPan80, high-speed stirring and evenly mixing; Get in the oil phase of starch hydrolyzate adding high-speed stirred, oil/water volume ratio is 15: 1 to 25: 1, continues to stir 20 minutes to forming small emulsion.Add cross-linking agent POCl3, stirring reaction, with the ethanol washing, lyophilization obtains the anionic starch nano-particle then;
(2) preparation of folic acid-amination polyethylene active material: folic acid is dissolved in dimethyl sulfoxine, stir and add nitrogen hydroxyl succinyl Asia (N-Hydroxysuccinimide down, NHS), nitrogen, nitrogen-dicyclohexyl carbon imidodicarbonic diamide (N, N '-Dicyclohexylcarbodi-imide, DCC) and the Polyethylene Glycol diamino, room temperature reaction; Add entry, remove by filter insoluble matter, the supernatant lyophilization, ether washs dry thing, obtains light yellow solid folic acid-amination polyethylene active material.
(3) preparation of folacin-starch nanometer granule. starch nanometer granule is dissolved in the deionized water, and ultra-sonic dispersion adds folic acid-amination polyethylene active material, and room temperature is educated altogether, centrifuge washing, precipitation is resuspended in PBS, and pH is 7.4,, obtain folacin-starch nanometer granule.
An also purpose of the present invention is meant folacin-starch nanometer granule is realized its application as the targeted delivery pharmaceutical carrier of antitumor drug.It can improve the targeting of medicine greatly, and can control the release of medicine, reduces the toxic and side effects of medicine simultaneously greatly.
Folacin-starch nanometer granule loads the cancer therapy drug process: folacin-starch nanometer granule is dissolved in the deionized water, add cancer therapy drug in solution, certain hour, centrifuge washing are hatched in vibration altogether under the room temperature, the precipitation vacuum drying obtains Powdered medicine carrying folacin-starch nanometer granule.The medicine carrying folacin-starch nanometer granule be by medicine by network in the folacin-starch nanometer granule inner space or medicine and the electrical be combined into of folacin-starch nanometer granule.Used cancer therapy drug has amycin, methotrexate, cytosine arabinoside.
Folic acid is as a kind of small-molecular weight vitamin, with respect to protein such as unimolecule antibody, have characteristics such as Stability Analysis of Structures, cheap, non-immunogenicity, and folic acid and folacin receptor adhesion are strong, folacin receptor has great expression and normal cell seldom has expression at most malignant cell films, if can be entered tumor cell, be a kind of targeting substance that using value is arranged very much by efficient mediation.In addition, be attached to the requirement of medicament slow release, the inventor is connected to folic acid on the nano-particle by valence bond, so just can effectively realize targeting identification and the medicament slow release of antitumor drug to tumor cell simultaneously, avoid medicine to Normocellular injury, improve the tumor treatment effect.And another important substance starch of the present invention is as a kind of biological natural material, has good biocompatibility, degradability and non-immunogenicity, and cheap and easy to get, is exactly medicine filler the most frequently used in the field of medicaments for a long time.Discovered in recent years starch can also obtain more characteristic through physics or chemical modification, and can be used as drug carrier material and be widely used in field of medicaments.But with starch is feedstock production nano-particle and effective modification of carrying out folic acid, and then is applied to drug delivery system and does not also see research.
Tumor-targeting pharmaceutical carrier of the present invention is the polyethyleneglycol derivative be combined into by anion crosslinked starch nano-particle and folic acid, has Stability Analysis of Structures, the characteristics that have no side effect, can the positively charged or neutral antitumor drug of enclose, medicine there is the effect of slow release, reduce the cytotoxicity of medicine, and by folic acid-folacin receptor mediated targeted tumor cell that enters, thereby realize the bioavailability of medicament slow release, cancer target, raising medicine, the effect of reduction poisonous side effect of medicine.And have good biocompatibility, degradability and non-immunogenicity, and various raw material is cheap and easy to get, simple and convenient, the mild condition of preparation technology.
Description of drawings
Fig. 1 is the atomic force phenogram of the prepared folacin-starch nanometer granule of the present invention, and average particulate diameter is 130nm.
The specific embodiment
Embodiment 1:
(1) preparation of starch nanometer granule
Starch is made into aqueous solution, adds thermal decomposition in the boiling water, up to the solution clarification, room temperature is placed cooling.The oil phase that preparation is made up of toluene and chloroform adds 2% surfactant SPan80, high-speed stirring and evenly mixing.Get in the oil phase of starch hydrolyzate adding high-speed stirred, oil/water volume ratio is 15: 1 to 25: 1, continues to stir 20 minutes to forming small emulsion.Add 0.01% cross-linking agent POCl3, about 30 minutes of stirring reaction, with the ethanol washing, lyophilization obtains the anionic starch nano-particle then.
(2) folic acid-amination Polyethylene Glycol (FA-PEG-NH
2) preparation of active substance
13.2 milligram folic acid is dissolved in 1 milliliter of DMSO, stirs down to add a certain amount of DCC and NHS, adds 100 milligrams of Polyethylene Glycol diaminos, room temperature reaction 4 hours.Add 5 ml waters, remove by filter insoluble matter, the supernatant lyophilization, ether washs dry thing, obtains light yellow solid folic acid-amination polyethylene active material.
(3) preparation of folacin-starch nanometer granule
Take by weighing the starch nanometer granule of embodiment 1 preparation, by weight, starch nanometer granule and folic acid-amination polyethylene active material is dissolved in the deionized water with 100: 1 ratio, ultra-sonic dispersion, room temperature was educated 3 hours altogether, centrifuge washing, and precipitation is resuspended in PBS (pH7.4), obtain folacin-starch nanometer granule, wherein folic acid accounts for the proportion 0.5 microgram/milligram of starch nanometer granule.
Embodiment 2:
The preparation of folacin-starch nanometer granule
Take by weighing the starch nanometer granule of embodiment 1 preparation, by weight, starch nanometer granule and folic acid-amination polyethylene active material is dissolved in the deionized water with 100: 3 ratio, ultra-sonic dispersion, room temperature was educated 3 hours altogether, centrifuge washing, and precipitation is resuspended in PBS (pH7.4), obtain folacin-starch nanometer granule, wherein folic acid accounts for the proportion 2.0 microgram/milligrams of starch nanometer granule.
Embodiment 3:
Folacin-starch nanometer granule loads anticancer drugs, doxorubicin
The folacin-starch nanometer granule 10mg that takes by weighing embodiment 2 preparations is dissolved in the 5ml deionized water, in solution, add the amycin that 0.5mg removes hydrochloric acid, certain hour is hatched in vibration altogether under the room temperature, and obtaining diameter is the medicament-carried nano granule of 150nm, and the useful load of amycin is 24 microgram/milligrams.
Embodiment 4:
Folacin-starch nanometer granule loads anticancer drugs, doxorubicin
The folacin-starch nanometer granule 10mg that takes by weighing embodiment 2 preparations is dissolved in the 5ml deionized water, in solution, add the amycin that 2.0mg removes hydrochloric acid, certain hour is hatched in vibration altogether under the room temperature, and obtaining diameter is the medicament-carried nano granule of 150nm, and the useful load of amycin is 33 microgram/milligrams.
Embodiment 5:
Folacin-starch nanometer granule loads the cancer therapy drug methotrexate
The folacin-starch nanometer granule 10mg that takes by weighing embodiment 2 preparations is dissolved in the 5ml deionized water, in solution, add the 1.0mg methotrexate, certain hour is hatched in vibration altogether under the room temperature, and obtaining diameter is the medicament-carried nano granule of 150nm, and the useful load of methotrexate is 45 microgram/milligrams.
Embodiment 6:
Folacin-starch nanometer granule loads the cancer therapy drug cytosine arabinoside
The folacin-starch nanometer granule 10mg that takes by weighing embodiment 2 preparations is dissolved in the 5ml deionized water, in solution, add the 1.0mg cytosine arabinoside, certain hour is hatched in vibration altogether under the room temperature, and obtaining diameter is the medicament-carried nano granule of 150nm, and the useful load of cytosine arabinoside is 25 microgram/milligrams.
Claims (4)
1, folacin-starch nanometer granule is characterized in that: be modified with active substance folic acid-amination Polyethylene Glycol on the anionic starch nano-particle.
2, the preparation method of the described folacin-starch nanometer granule of preparation claim 1 is prepared according to the following steps:
(1) preparation of starch nanometer granule: starch is made into aqueous solution, adds thermal decomposition in the boiling water, up to the solution clarification, room temperature is placed cooling; The oil phase that preparation is made up of toluene and chloroform adds surfactant SPan80, high-speed stirring and evenly mixing; Get in the oil phase of starch hydrolyzate adding high-speed stirred, oil/water volume ratio is 15: 1 to 25: 1, continues to stir 20 minutes to forming small emulsion.Add cross-linking agent POCl3, stirring reaction, with the ethanol washing, lyophilization obtains the anionic starch nano-particle then;
(2) preparation of folic acid-amination polyethylene active material: folic acid is dissolved in dimethyl sulfoxine, stirs to add nitrogen-hydroxyl succinyl Asia, nitrogen, nitrogen-dicyclohexyl carbon imidodicarbonic diamide and Polyethylene Glycol diamino, room temperature reaction down; Add entry, remove by filter insoluble matter, the supernatant lyophilization, ether washs dry thing, obtains light yellow solid folic acid-amination polyethylene active material.
(3) preparation of folacin-starch nanometer granule. starch nanometer granule is dissolved in the deionized water, and ultra-sonic dispersion adds folic acid-amination polyethylene active material, and room temperature is educated altogether, centrifuge washing, precipitation is resuspended in PBS, and pH is 7.4,, obtain folacin-starch nanometer granule.
3, the application of the described folacin-starch nanometer granule of claim 1 is characterized in that: folacin-starch nanometer granule is realized its application as the targeted delivery pharmaceutical carrier of antitumor drug.
4, the application of folacin-starch nanometer granule according to claim 3, it is characterized in that: folacin-starch nanometer granule is dissolved in the deionized water, in solution, add cancer therapy drug, vibration is hatched altogether under the room temperature, centrifuge washing, the precipitation vacuum drying obtains Powdered medicine carrying folacin-starch nanometer granule, the medicine carrying folacin-starch nanometer granule be by medicine by network in the folacin-starch nanometer granule inner space or medicine and the electrical be combined into of folacin-starch nanometer granule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100311063A CN100387302C (en) | 2006-01-05 | 2006-01-05 | Folacin-starch nanometer granule, its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100311063A CN100387302C (en) | 2006-01-05 | 2006-01-05 | Folacin-starch nanometer granule, its preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1840200A true CN1840200A (en) | 2006-10-04 |
CN100387302C CN100387302C (en) | 2008-05-14 |
Family
ID=37029500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100311063A Expired - Fee Related CN100387302C (en) | 2006-01-05 | 2006-01-05 | Folacin-starch nanometer granule, its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100387302C (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102580109A (en) * | 2012-03-02 | 2012-07-18 | 河南师范大学 | Anti-cancer drug carrier and method for producing same |
CN107375237A (en) * | 2017-09-08 | 2017-11-24 | 吉林大学 | Starch capsules with reduction response a kind of of modified with folic acid and preparation method thereof |
CN110960508A (en) * | 2019-11-13 | 2020-04-07 | 湖北大学 | Starch nano-particle with protein adsorption resistance and targeting capability and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100340599C (en) * | 2003-06-09 | 2007-10-03 | 湖南大学 | Nano granule of polylysine amylum and its preparation method as well as application gene carrier |
CN1218983C (en) * | 2003-06-26 | 2005-09-14 | 上海复康医药科技发展有限公司 | Folic acid-polydiol compound and its medicinal composition |
CN100423778C (en) * | 2003-11-25 | 2008-10-08 | 上海复旦张江生物医药股份有限公司 | Folic acid receptor targeted liposome medicine carrier, its preparation and application |
-
2006
- 2006-01-05 CN CNB2006100311063A patent/CN100387302C/en not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102580109A (en) * | 2012-03-02 | 2012-07-18 | 河南师范大学 | Anti-cancer drug carrier and method for producing same |
CN102580109B (en) * | 2012-03-02 | 2013-11-06 | 河南师范大学 | Anti-cancer drug carrier and method for producing same |
CN107375237A (en) * | 2017-09-08 | 2017-11-24 | 吉林大学 | Starch capsules with reduction response a kind of of modified with folic acid and preparation method thereof |
CN110960508A (en) * | 2019-11-13 | 2020-04-07 | 湖北大学 | Starch nano-particle with protein adsorption resistance and targeting capability and preparation method thereof |
CN110960508B (en) * | 2019-11-13 | 2021-11-23 | 湖北大学 | Starch nano-particle with protein adsorption resistance and targeting capability and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN100387302C (en) | 2008-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Khalil et al. | Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery | |
Yan et al. | Biotin and arginine modified hydroxypropyl-β-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel | |
Ji et al. | Preparation, characterization and in vitro release of chitosan nanoparticles loaded with gentamicin and salicylic acid | |
Azhar et al. | A study on sustained release formulations for oral delivery of 5-fluorouracil based on alginate–chitosan/montmorillonite nanocomposite systems | |
Sarmento et al. | Development and comparison of different nanoparticulate polyelectrolyte complexes as insulin carriers | |
Wang et al. | Polylactide-tethered prodrugs in polymeric nanoparticles as reliable nanomedicines for the efficient eradication of patient-derived hepatocellular carcinoma | |
Nimje et al. | Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting | |
Ye et al. | The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes | |
Ameli et al. | Targeted delivery of capecitabine to colon cancer cells using nano polymeric micelles based on beta cyclodextrin | |
Soni et al. | Controlled delivery of Gemcitabine Hydrochloride using mannosylated poly (propyleneimine) dendrimers | |
Hussein‐Al‐Ali et al. | Preparation of chitosan nanoparticles as a drug delivery system for perindopril erbumine | |
AU2008240545A1 (en) | Nanoparticles comprising a cyclodextrin and a biologically active molecule and uses thereof | |
CN101106974B (en) | Cholanic acid-chitosan complex forming self-aggregates and preparation method thereof | |
Ji et al. | Preparation and evaluation of O-carboxymethyl chitosan/cyclodextrin nanoparticles as hydrophobic drug delivery carriers | |
Shah et al. | Statistical modeling of zaltoprofen loaded biopolymeric nanoparticles: Characterization and anti-inflammatory activity of nanoparticles loaded gel | |
Xiong et al. | Amphiphilic Cholic‐Acid‐Modified Dextran Sulfate and its Application for the Controlled Delivery of Superoxide Dismutase | |
Huang et al. | Self-assembled nanoparticles based on a cationic conjugated polymer/hyaluronan–cisplatin complex as a multifunctional platform for simultaneous tumor-targeting cell imaging and drug delivery | |
CN110152008B (en) | Preparation method of starch-based hydrophilic-hydrophobic two-phase delivery system | |
Ciekot et al. | Hydroxyethylcellulose as a methotrexate carrier in anticancer therapy | |
CN1840200A (en) | Folacin-starch nanometer granule, its preparation method and application | |
Nazlı et al. | In-vitro evaluation of dendrimeric formulation of oxaliplatin | |
Ahmari et al. | A green approach for preparation of chitosan/hydroxyapatite/graphitic carbon nitride hydrogel nanocomposite for improved 5-FU delivery | |
Naskar et al. | A smart gelatin nanoparticle for delivery of metoprolol succinate: A strategy for enhancing the therapeutic efficacy by improving bioavailability | |
Pandey et al. | Using 5-fluorouracil-encored plga nanoparticles for the treatment of colorectal cancer: the in-vitro characterization and cytotoxicity studies. | |
CN105940041B (en) | Prepare the novel polymer platform of nano-hydrogel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080514 Termination date: 20120105 |